期刊文献+

Pulse-spray catheter directed thrombolysis in patients with recent onset or deterioration of lower extremity ischemia 被引量:4

原文传递
导出
摘要 Background The recent onset or deterioration of lower extremity ischemia is highly associated with intravascular thrombus.Treatment of these thrombotic occlusions is challenging.Pulse-spray catheter directed thrombolysis (PS-CDT) refers to the technique of intermittent forcefully injecting the thrombolytic agent into the thrombus to fragment it and increase the surface area available for enzymatic action.This study was designed to evaluate the efficacy and safety of PS-CDT in patients with recent onset or deterioration of lower extremity ischemia.Methods From August 2008 to March 2009,44 patients with acute or chronic lower extremity ischemia were recruited in this prospective study,which included 37 men and 7 women ranging from 15 to 83 years old (mean age (51.1±17.4) years).PS-CDT through a multi-side-hole thrombolytic catheter by using urokinase was conducted in all patients.The progression of thrombolysis was assessed and graded by angiography.Adjunctive therapies were used to correct underlying lesions.The follow-up period was 12 months.Results In the 44 patients,the average total dose of urokinase for each patient was (2120000±1100000) IU (median 2000000 IU),with a median duration of lysis of 48 hours.The rate of initial technical success was 97.7%.The rate of clinically successful lysis was 81.8%.Early (〈30 days) and late (from 30 days to 12 months) amputation rates were both 4.5% (2/44).The overall amputation rate was 9.1% (4/44).No mortality was recorded during thrombolysis and follow-up period (12 months).No major bleeding or allergic reaction was seen during thrombolytic therapy.11.4% had symptoms of distal embolization.The primary patency rate for the arteries that were clinically successfully thrombolyzed as compared with those that failed to lysis was 83.3% vs.57.1%,respectively,at 1 year.Conclusions PS-CDT,combined with adjunctive therapies,is associated with good safety and efficacy in recent-onset or deterioration of lower extremity ischemia.Successful thrombolysis may be accompanied by better outcomes.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第2期188-192,共5页 中华医学杂志(英文版)
  • 相关文献

参考文献20

  • 1Dosluoglu HH, Harris LM. Endovascular management of subacute lower extremity ischemia. Semin Vasc Surg 2008; 21: 167-179.
  • 2Shammas NW, Dippel EJ. Evidence-based management of peripheral vascular disease. Curr Atheroscler Rep 2005; 7: 358-363.
  • 3Shammas NW, Dippel E J, Shammas (5, Gayton L, Coiner D, Jerin M. Dethrombosis of the lower extremity arteries using the power-pulse spray technique in patients with recent onset thrombotic occlusions: results of the DETHROMBOSIS Registry. J Endovasc Ther 2008; 15: 570-579.
  • 4Shammas NW, Weissman N J, Coiner D, Shammas G, Jerin M, Christensen L. Dethrombosis of lower extremity thrombus by local delivery of thrombolysis using ClearWay transcatheter balloon irrigation: a feasibility study. Cardiovasc Revasc Med 2011; 12: 350-354.
  • 5Working Party on Thrombolysis in the Management of Limb Ischemia. Thrombolysis in the management of lower limbperipheral arterial occlusion-a consensus document. J gasc lnterv Radiol 2003; 14: $337-$349.
  • 6Rutherford FD, Gupta SK, Karmody A, Whittemore AD, Ernst CB, Jamieson MS. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg 1987; 5: 501-503.
  • 7Buller HR, Cohen AT, Davidson B, Decousus H, Gallus AS, Gent M, et al. ldraparinux versus standard therapy for venous thromboembolic disease. N Eugl J Med 2(107; 357: 1094-1104.
  • 8The Investigators of STILE. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994; 220: 251-266; discussion 266-258.
  • 9Kuoppala M, Franzen S, Lindblad B, Acosta S. Long-term prognostic factors after thrombolysis tbr lower limb ischemia. J Vasc Surg 2008; 47: 1243-1250.
  • 10Geier B, Mumme A, Koster O, Marpe B, Hummel T, Asciutto G. Is initial success of thrombolytic therapy with rt-PA in patients with lower limb ischemia durable? A long-term follow-up series. Vasa 2007; 36: 114-120.

同被引文献30

  • 1李杰,常光其,李松奇,李晓曦,王深明,吕伟明.下肢慢性缺血合并急性血栓形成的外科治疗[J].中国血管外科杂志(电子版),2011,3(4):226-228. 被引量:6
  • 2田硕,黄新天,殷敏毅,陆信武,李维敏,黄英,陆民,蒋米尔.下肢动脉粥样硬化闭塞症腔内治疗后再闭塞的原因分析及应对策略[J].中国血管外科杂志(电子版),2013,5(2):83-85. 被引量:12
  • 3Dotter CT, Rosch J, Seaman AI. Selective clot lysis with low-dose streptokinase[J]. Radiology, 1974, 111(1): 31.
  • 4Conrad MF, Shepard AD, Rubinfeld IS, et al. Long-term results of catheter-directed thrombolysis to treat infrainguinal bypass graf occlusion: the urikinase era[J]. J Vasc Surg, 2003, 37(5): 1009-1016.
  • 5Byrne RM, Taha AG, Avqerinos E, et al. Contemporary outcomes of endovascular interventions for acute limb ischemia [J]. J Vasc Surg, 2014, 59(4): 988-995.
  • 6Joseph C, Chet RR, Andrew KS, et al. Usefulness of catheter-directed thrombolysis using alteplase in peripheral vascular occlusion [J]. BUMC Proceeding, 2001, 14(1): 3-7.
  • 7Matthew DM, Amy BR, Urs AL, ct al. Physiology in medicine peripheral arterial disease[J]. J Appl Physiol, 2013, 115(9): 1219-1226.
  • 8Alonso-Coello P, Bellmunt S, MeGorrian C, et al. Antithrombotic therapy in peripheral artery disease: antithrombotie therapy and prevention of thrombosis, 9thed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(Suppl 2): S669-S690.
  • 9Sebastian AT, Robinson GJ, Dyet YF. Long-term outcomes of low- dose catheter-directed thrombolytic therapy: a 5-year single-center experience[J]. J Vasc Interv Radiol, 2010, 21(7): 1004-1010.
  • 10Han SM, Weaver FA, Comerota AJ. Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion(PAO) [J]. J Vasc Surg, 2010, 51(3): 600-609.

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部